Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-κB Signaling Pathway in Human Breast Cancer Cells

Figure 2

Effect of Oroxylin A on proliferation of MDA-MB-231 cells. (a-b) Flow cytometry assays were performed to analyze the cell cycle progression when MDA-MB-231 cells were treated with OA 24 h later. (c) The expressions of proliferation-related protein CDK2, CyclinE, and p27 were detected by western blot analysis. Data are expressed as mean ± SD. < 0.05, < 0.01 versus control.

(a)

(b)

(c)